Am J Psychiatry 160:790-792, April 2003
© 2003 American Psychiatric Association
Suicide Rates in Clinical Trials of SSRIs, Other Antidepressants, and Placebo: Analysis of FDA Reports
Arif Khan, M.D.,
Shirin Khan,
Russell Kolts, Ph.D., and
Walter A. Brown, M.D.
OBJECTIVE: Previous reports suggesting that selective serotonin reuptake inhibitor (SSRI) use is associated with increased suicidal risk have not assessed completed suicides. The authors analyzed reports from randomized controlled trials to compare suicide rates among depressed patients assigned to an SSRI, other antidepressants, or placebo. METHOD: Food and Drug Administration (FDA) summary reports of the controlled clinical trials for nine modern FDA-approved antidepressants provided data for comparing rates of suicide. RESULTS: Of 48,277 depressed patients participating in the trials, 77 committed suicide. Based on patient exposure years, similar suicide rates were seen among those randomly assigned to an SSRI (0.59%, 95% confidence interval [CI]=0.31%–0.87%), a standard comparison antidepressant (0.76%, 95% CI=0.49%–1.03%), or placebo (0.45%, 95% CI=0.01%–0.89%). CONCLUSIONS: These findings fail to support either an overall difference in suicide risk between antidepressant- and placebo-treated depressed subjects in controlled trials or a difference between SSRIs and either other types of antidepressants or placebo.
This article has been cited by other articles:
|
|
|
|
 
A. Qaseem, V. Snow, T. D. Denberg, M. A. Forciea, D. K. Owens, and for the Clinical Efficacy Assessment Subcommittee
Using Second-Generation Antidepressants to Treat Depressive Disorders: A Clinical Practice Guideline from the American College of Physicians
Ann Intern Med,
November 18, 2008;
149(10):
725 - 733.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Gartlehner, B. N. Gaynes, R. A. Hansen, P. Thieda, A. DeVeaugh-Geiss, E. E. Krebs, C. G. Moore, L. Morgan, and K. N. Lohr
Comparative Benefits and Harms of Second-Generation Antidepressants: Background Paper for the American College of Physicians
Ann Intern Med,
November 18, 2008;
149(10):
734 - 750.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Kotzalidis, I. Pacchiarotti, G. Manfredi, V. Savoja, C. Torrent, L. Mazzarini, C. Tatarelli, B. Amann, S. Di Marzo, J. Sanchez-Moreno, et al.
Ethical questions in human clinical psychopharmacology: should the focus be on placebo administration?
J Psychopharmacol,
August 1, 2008;
22(6):
590 - 597.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A Erlangsen, V Canudas-Romo, and Y Conwell
Increased use of antidepressants and decreasing suicide rates: a population-based study using Danish register data
J Epidemiol Community Health,
May 1, 2008;
62(5):
448 - 454.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Laje, S. Paddock, H. Manji, A. J. Rush, A. F. Wilson, D. Charney, and F. J. McMahon
Genetic Markers of Suicidal Ideation Emerging During Citalopram Treatment of Major Depression
Focus,
January 1, 2008;
6(1):
69 - 79.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. E. Simon and J. Savarino
Suicide Attempts Among Patients Starting Depression Treatment With Medications or Psychotherapy
Focus,
January 1, 2008;
6(1):
80 - 85.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Laje, S. Paddock, H. Manji, A. J. Rush, A. F. Wilson, D. Charney, and F. J. McMahon
Genetic Markers of Suicidal Ideation Emerging During Citalopram Treatment of Major Depression
Am J Psychiatry,
October 1, 2007;
164(10):
1530 - 1538.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. E. Simon and J. Savarino
Suicide Attempts Among Patients Starting Depression Treatment With Medications or Psychotherapy
Am J Psychiatry,
July 1, 2007;
164(7):
1029 - 1034.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. D. Gibbons, C. H. Brown, K. Hur, S. M. Marcus, D. K. Bhaumik, and J. J. Mann
Relationship Between Antidepressants and Suicide Attempts: An Analysis of the Veterans Health Administration Data Sets
Am J Psychiatry,
July 1, 2007;
164(7):
1044 - 1049.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. H. Perlis, S. Purcell, M. Fava, J. Fagerness, A. J. Rush, M. H. Trivedi, and J. W. Smoller
Association Between Treatment-Emergent Suicidal Ideation With Citalopram and Polymorphisms Near Cyclic Adenosine Monophosphate Response Element Binding Protein in the STAR*D Study
Arch Gen Psychiatry,
June 1, 2007;
64(6):
689 - 697.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. A. Kurdyak, D. N. Juurlink, and M. M. Mamdani
The Effect of Antidepressant Warnings on Prescribing Trends in Ontario, Canada
Am J Public Health,
April 1, 2007;
97(4):
750 - 754.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Rubino, N. Roskell, P. Tennis, D. Mines, S. Weich, and E. Andrews
Risk of suicide during treatment with venlafaxine, citalopram, fluoxetine, and dothiepin: retrospective cohort study
BMJ,
February 3, 2007;
334(7587):
242 - 242.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. A. Fischer, A. D. Servi, J. M. Polinski, and P. S. Wang
Restrictions on Antidepressant Medications for Children: A Review of Medicaid Policy
Psychiatr Serv,
January 1, 2007;
58(1):
135 - 138.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Tiihonen, J. Lonnqvist, K. Wahlbeck, T. Klaukka, A. Tanskanen, and J. Haukka
Antidepressants and the Risk of Suicide, Attempted Suicide, and Overall Mortality in a Nationwide Cohort
Arch Gen Psychiatry,
December 1, 2006;
63(12):
1358 - 1367.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. E. Simon
How Can We Know Whether Antidepressants Increase Suicide Risk?
Am J Psychiatry,
November 1, 2006;
163(11):
1861 - 1863.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. E. McKeown, S. P. Cuffe, and R. M. Schulz
US Suicide Rates by Age Group, 1970-2002: An Examination of Recent Trends
Am J Public Health,
October 1, 2006;
96(10):
1744 - 1751.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Healy
The antidepressant tale: figures signifying nothing?
Advan. Psychiatr. Treat.,
September 1, 2006;
12(5):
320 - 327.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. P Ebmeier
No apparent difference in suicide risk between older and newer antidepressants although older drugs may increase risk of suicide attempt during the first month of treatment.
Evid. Based Ment. Health,
August 1, 2006;
9(3):
82 - 82.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Olfson, S. C. Marcus, and D. Shaffer
Antidepressant drug therapy and suicide in severely depressed children and adults: a case-control study.
Arch Gen Psychiatry,
August 1, 2006;
63(8):
865 - 872.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Healy
Did regulators fail over selective serotonin reuptake inhibitors?
BMJ,
July 8, 2006;
333(7558):
92 - 95.
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. N. Juurlink, M. M. Mamdani, A. Kopp, and D. A. Redelmeier
The Risk of Suicide With Selective Serotonin Reuptake Inhibitors in the Elderly
Am J Psychiatry,
May 1, 2006;
163(5):
813 - 821.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. L. Gluud
Bias in Clinical Intervention Research
Am. J. Epidemiol.,
March 15, 2006;
163(6):
493 - 501.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. J. Baldessarini, M. Pompili, and L. Tondo
Suicidal risk in antidepressant drug trials.
Arch Gen Psychiatry,
March 1, 2006;
63(3):
246 - 248.
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. E. Simon, J. Savarino, B. Operskalski, and P. S. Wang
Suicide Risk During Antidepressant Treatment
Am J Psychiatry,
January 1, 2006;
163(1):
41 - 47.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. J. Mann, A. Apter, J. Bertolote, A. Beautrais, D. Currier, A. Haas, U. Hegerl, J. Lonnqvist, K. Malone, A. Marusic, et al.
Suicide Prevention Strategies: A Systematic Review
JAMA,
October 26, 2005;
294(16):
2064 - 2074.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. A. Hansen, G. Gartlehner, K. N. Lohr, B. N. Gaynes, and T. S. Carey
Efficacy and Safety of Second-Generation Antidepressants in the Treatment of Major Depressive Disorder
Ann Intern Med,
September 20, 2005;
143(6):
415 - 426.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. C. Kessler, P. Berglund, G. Borges, M. Nock, and P. S. Wang
Trends in Suicide Ideation, Plans, Gestures, and Attempts in the United States, 1990-1992 to 2001-2003
JAMA,
May 25, 2005;
293(20):
2487 - 2495.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. H. Kellner, M. Fink, R. Knapp, G. Petrides, M. Husain, T. Rummans, M. Mueller, H. Bernstein, K. Rasmussen, K. O'Connor, et al.
Relief of Expressed Suicidal Intent by ECT: A Consortium for Research in ECT Study
Am J Psychiatry,
May 1, 2005;
162(5):
977 - 982.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Dubicka and I. Goodyer
Should we prescribe antidepressants to children?
Psychiatr. Bull.,
May 1, 2005;
29(5):
164 - 167.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Caballero and M. C. Nahata
Selective serotonin-reuptake inhibitors and suicidal ideation and behavior in children
Am. J. Health Syst. Pharm.,
April 15, 2005;
62(8):
864 - 867.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Cipriani, C. Barbui, and J. R Geddes
Suicide, depression, and antidepressants
BMJ,
February 19, 2005;
330(7488):
373 - 374.
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Gunnell, J. Saperia, and D. Ashby
Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review
BMJ,
February 19, 2005;
330(7488):
385.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Fergusson, S. Doucette, K. C. Glass, S. Shapiro, D. Healy, P. Hebert, and B. Hutton
Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials
BMJ,
February 19, 2005;
330(7488):
396.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Treatment for Adolescents With Depression Study T
Fluoxetine, Cognitive-Behavioral Therapy, and Their Combination for Adolescents With Depression: Treatment for Adolescents With Depression Study (TADS) Randomized Controlled Trial
JAMA,
August 18, 2004;
292(7):
807 - 820.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Fricchione
Generalized Anxiety Disorder
N. Engl. J. Med.,
August 12, 2004;
351(7):
675 - 682.
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Gunnell and D. Ashby
Antidepressants and suicide: what is the balance of benefit and harm
BMJ,
July 3, 2004;
329(7456):
34 - 38.
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. J. Nutt
Death and Dependence: Current Controversies over the Selective Serotonin Reuptake Inhibitors
J Psychopharmacol,
December 1, 2003;
17(4):
355 - 364.
[Abstract]
[PDF]
|
|
|
|
|
|
|
M. Olfson, D. Shaffer, S. C. Marcus, and T. Greenberg
Relationship Between Antidepressant Medication Treatment and Suicide in Adolescents
Arch Gen Psychiatry,
October 1, 2003;
60(10):
978 - 982.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. K. Varley
Psychopharmacological Treatment of Major Depressive Disorder in Children and Adolescents
JAMA,
August 27, 2003;
290(8):
1091 - 1093.
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. H Ankarberg
Antidepressant prescribing and suicide: Antidepressants do not reduce suicide rates
BMJ,
July 31, 2003;
327(7409):
288 - 289.
[Full Text]
|
|
|
|
|
|
|
Type of antidepressant is not linked to suicide rates
BMJ,
July 10, 2003;
327(7406):
.
[Full Text]
[PDF]
|
|
|
|
|
|
|
Antidepressants Don't Cause Suicide
Journal Watch Women's Health,
June 4, 2003;
2003(604):
8 - 8.
[Full Text]
|
|
|
|
|
|
|
J. Rosack
Psychiatr News,
April 18, 2003;
38(8):
46 - 47.
[Full Text]
|
|
|
Get information about faster international access.
Privacy Policy
Copyright © 2003
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|
